Home › Atrial Fibrillation › Virginia
Atrial Fibrillation clinical trials in Virginia
15 studies for Atrial Fibrillation are looking for participants at sites in Virginia.
Cities in Virginia
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- University of Virginia, Charlottesville
- James River Cardiology, Richmond
- Virginia Commonwealth University, Richmond
RecruitingPhase 3
Ages 22 to 85 · All sexes · Updated Sep 30, 2026 · NCT05836987A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- Winchester Medical Center, Winchester
Recruiting
Ages 22 and older · All sexes · Updated Sep 30, 2026 · NCT07227532Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Carient Heart & Vascular, Manassas
- Conquest Research, Vienna
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07626411PULSED AF Post-Approval Study
- University of Virginia Medical Center, Charlottesville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06578104Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Centra Health, Inc. dba Stroobants Cardiovascular Center, Lynchburg
- Bon Secours St. Marys, Midlothian
- CJW Medical Center, Richmond
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- The Rector and Visitors of the University of Virginia, Charlottesville
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Conquest Research, Vienna
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07430956Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- Inova Fairfax Hospital, Falls Church
- Centra Medical Group Stroobants Cardiovascular Center, Lynchburg
- Sentara Norfolk General Hospital, Newport News
Recruiting
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07298473Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1018, Falls Church
- Anthos Investigational site 9817, Fredericksburg
- Anthos Investigative Site 1009, Roanoke
- and 1 more
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- University of Virginia Health System, Charlottesville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT04045665Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- UVA Medical Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Bon Secours St. Mary's Hospital, Richmond
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046REPRESENT-PF Registry
- Valley Health System, Winchester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT07535268EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
- Virginia Commonwealth University, Richmond
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 12, 2026 · NCT06212791The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Centra Health, Inc.dba Stroobants Cardiovascular Center, Lynchburg
- Bon Secours Medical Group - Richmond Specialty Care, Richmond
- Valley Health System, Winchester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT06324201CardioFocus HeartLight Post-Approval Study
- University Of Virginia Health System, Charlottesville
Recruiting
Ages 18 and older · All sexes · Updated Aug 20, 2024 · NCT03168659From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.